Literature DB >> 26905071

Neurologic Complications of Commonly Used Drugs in the Hospital Setting.

Elliot T Dawson1, Sara E Hocker2,3.   

Abstract

This chapter reviews the neurologic complications of medications administered in the hospital setting, by class, introducing both common and less common side effects. Detail is devoted to the interaction between pain, analgesia, sedation, and their residual consequences. Antimicrobials are given in nearly every hospital setting, and we review their capacity to produce neurologic sequelae with special devotion to cefepime and the antiviral treatment of human immunodeficiency virus. The management of hemorrhagic stroke has become more complex with the introduction of novel oral anticoagulants, and we provide an update on what is known about reversal of the new oral anticoagulants. Both central and peripheral nervous system complications of immunosuppressants and chemotherapies are reviewed. Because diagnosis is generally based on clinical acumen, alone, neurotoxic syndromes resulting from psychotropic medications may be easily overlooked until severe dysautonomia develops. We include a practical approach to the diagnosis of serotonin syndrome and neuroleptic malignant syndrome.

Entities:  

Keywords:  Drugs; Hospital; Medications; Neurologic complications

Mesh:

Substances:

Year:  2016        PMID: 26905071     DOI: 10.1007/s11910-016-0636-7

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  128 in total

1.  Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring.

Authors:  Linda Mileshkin; Richard Stark; Bruce Day; John F Seymour; Jerome B Zeldis; H Miles Prince
Journal:  J Clin Oncol       Date:  2006-08-28       Impact factor: 44.544

Review 2.  The diagnosis of dystonia.

Authors:  Howard L Geyer; Susan B Bressman
Journal:  Lancet Neurol       Date:  2006-09       Impact factor: 44.182

Review 3.  Clinical features and outcomes of posterior reversible encephalopathy syndrome following bevacizumab treatment.

Authors:  R C S Seet; A A Rabinstein
Journal:  QJM       Date:  2011-08-24

Review 4.  Neurotoxicity with antimicrobials in the elderly: a review.

Authors:  Arun Mattappalil; Kari A Mergenhagen
Journal:  Clin Ther       Date:  2014-11-04       Impact factor: 3.393

5.  Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk.

Authors:  T G Phan; M Koh; E F Wijdicks
Journal:  Arch Neurol       Date:  2000-12

Review 6.  Mortality from neuroleptic malignant syndrome.

Authors:  A Shalev; H Hermesh; H Munitz
Journal:  J Clin Psychiatry       Date:  1989-01       Impact factor: 4.384

7.  Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection.

Authors:  Philip M Grant; Lauren Komarow; Janet Andersen; Irini Sereti; Savita Pahwa; Michael M Lederman; Joseph Eron; Ian Sanne; William Powderly; Evelyn Hogg; Carol Suckow; Andrew Zolopa
Journal:  PLoS One       Date:  2010-07-01       Impact factor: 3.240

8.  Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national survey.

Authors:  J H Hansen-Flaschen; S Brazinsky; C Basile; P N Lanken
Journal:  JAMA       Date:  1991-11-27       Impact factor: 56.272

Review 9.  AANA journal course. Update for nurse anesthetists. Neuroleptic malignant syndrome.

Authors:  Steve Waldorf
Journal:  AANA J       Date:  2003-10

Review 10.  Clinical review: intensive care unit acquired weakness.

Authors:  Greet Hermans; Greet Van den Berghe
Journal:  Crit Care       Date:  2015-08-05       Impact factor: 9.097

View more
  1 in total

1.  Myoclonus induced by amoxicillin-clavulanic acid.

Authors:  Alejandro Viloria-Alebesque; Marina Povar-Echeverría; María Jesús Bruscas-Alijarde; Anyuli Gracia-Gutiérrez; Leticia Royo-Trallero; Patricia Al-Cheikh-Felices
Journal:  Epilepsy Behav Rep       Date:  2020-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.